Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

New Book Takes the First Sober Look at FDA-Approved Medications for Alcoholism: A Prescription for Alcoholics

Never heard of medication for alcoholism? You're not alone. Eighty-eight thousand Americans will die this year from alcohol dependence. Most will do so without ever knowing of the FDA-approved medications that might have saved their lives. A controversial new book - 'A Prescription for Alcoholics - Medications for Alcoholism' - takes a first sober look at medication for alcoholics, including the research behind them, and why nobody - including physicians - seems to know about them.


News provided by

Linda Burlison

Mar 07, 2016, 09:15 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, March 7, 2016 /PRNewswire/ -- Most people (including physicians and alcoholics) are unaware of the FDA-approved medications to fight alcoholism, despite the fact that the US government calls them the 'standard of care for the treatment of alcoholism.'[1]

Photo - http://photos.prnewswire.com/prnh/20160303/340348

Continue Reading

Instead of medical treatment, the vast majority of doctors send treatment-seeking alcoholics to Alcoholics Anonymous-based 12-step programs which result in a dismal failure rate estimated at 90 percent.[2]

A new book is tackling this treatment problem head on.

'A Prescription for Alcoholics – Medications for Alcoholism' by author Linda Burlison is the first book ever published about FDA-approved medications for alcoholism.

The 550-page book is an extensive look at drugs like naltrexone, acamprosate, baclofen, topiramate, gabapentin, nalmefene and others.

Dr. Nora Volkow, the Director of the US National Institute on Drugs, and Dr. George Koob, Director of the US National Institute on Drug Abuse are spearheading a new understanding of alcoholism as a complex brain disease, and the medication that can treat it.[3]

Drs. Volkow and Koob are just two of thousands of researchers whose clinical research into medication for alcoholism forms the body of evidence the book cites.

Written in plain English, the book highlights hundreds of studies conducted over many decades into medication that can reduce cravings, help manage alcohol consumption and help troubled drinkers abstain from drinking completely.

A Prescription for Alcoholics – Medications for Alcoholism is available exclusively from Amazon in Kindle and paperback. The first chapter can be read for free through Amazon's 'Look Inside' feature. 

The book provides answers to important questions about safety, liver toxicity, side effects, dosage and more.

Most importantly it provides easy-to-read information which can be brought to a doctor's office to help a patient and their physician make an informed decision about treatment choices together. 

Burlison began researching for a friend who was fighting a battle with alcoholism.  "I started to come across literally hundreds of studies in the world's top medical and scientific journals showing their effectiveness. However, when we asked doctors about them, they had never heard of them. I realized there was a major disconnect between the medical research and what doctors were prescribing," says Burlison.

"Because North American pharmaceutical companies are not marketing them, and 12-step programs like AA don't talk about them, even though research proves these drugs are very effective, nobody knows about them."

"It's a tragedy with massive proportions. I know people who have lost daughters, wives, husbands, friends to this disease, and never knew medication was a real treatment option," says Burlison. 

In the United States it is estimated that 18 million Americans suffer from alcoholism, and the World Health Organization has called it the "number one killer."[4]

"Most of the medications, like acamprosate, naltrexone, baclofen, topiramate, gabapentin and several others are generic, and three of those can only be prescribed off-label for alcoholism. These factors mean no pharmaceutical rep will even mention them to a doctor."

"12-step programs like Alcoholics Anonymous look down on the use of medication. AA is an 80-year old religion-based program which strictly follows a structure developed in the thirties. They will not talk about medical options at meetings."[5]

"And 12-Step programs only support complete abstinence – whereas some of these medications help drinkers reduce and manage their drinking, and don't require complete abstinence."

"There is an enormous gap in our system. There are thousands of top scientists working in this area right now, but there is a gap between their research findings and what the public knows about evidence-based medical care for alcoholics. This book bridges the gap.  It provides a picture of the medications that exist, points you to the research behind them as well as additional resources, and gives you what you need to have an informed conversation with your doctor," says Burlison.

Burlison likens the 'learning curve' for medications that can help dependent drinkers to the emergence of antidepressants in the late '80s.

"For example, before drugs like Prozac became available, there was less understanding of depression as an actual illness. But as it and other medications in its class were prescribed and we saw results, treatment with medication became more accepted. As a result, society developed a greater understanding of depression as a complex medical condition needing treatment."

"Today, we are at a similar place with alcoholism. When doctors and dependent drinkers start to learn about these medications and start to see their effectiveness, we'll also gain a better societal understanding that alcoholism is, in fact, another complex brain disease, not a character weakness or something that can only be resolved for everyone in a church basement."

Book Details:

  • Title: A Prescription for Alcoholics – Medications for Alcoholism
  • Author: Linda Burlison
  • Paperback Published: March 2016
  • ISBN: 978-0997107609
  • Retail Price: $0.99 (digital); $18.99 (paperback)
  • Publisher: Stonecutter Books (StonecutterBooks.com)
  • Contact: [email protected]
  • Amazon Link:  http://www.amazon.com/Prescription-Alcoholics-Medications-Alcoholism/dp/099710760X

Additional Sources of Information about Medication for Alcoholism

US Government Reports:

  • "Addiction Medicine: Closing the Gap Between Science and Medicine - Report", National Centre on Addiction and Substance Abuse from http://www.casacolumbia.org/addiction-research/reports/addiction-medicine
  • "Medications for the Treatment of Alcohol Use Disorder – A Brief Guide", Substance Abuse and Mental Health Administration

Popular Press:

  • "Drugs for Alcoholism Don't Have to Lead to Sobriety FDA Says",  Bloomberg News, February 2015
  • "AA Saved My Life, But Now I've Lost my Faith", The Guardian, November 2015 at http://www.theguardian.com/society/2015/nov/29/alcoholics-anonymous-saved-my-life-but-i-lost-my-faith
  • "Does Rehab Work", Scientific American, Jul 2011

Scientific Research:

  • Research from leading medical journals can be found at  http://www.aprescriptionforalcoholics.com/resources/research-and-journal-articles/

Leading Scientific Authorities Researching in this Area:

  • Dr. Nora Volkow, the Director of the US National Institute on Drugs
  • Dr. George Koob, Director of the US National Institute on Drug Abuse
  • Dr. Barbara Mason, Director, Laboratory of Clinical Psychopharmacology and Pearson Center for Alcoholism and Addiction Research
  • Dr. Carolina L Haass-Koffler, Postdoctoral Fellow, Center for Alcohol and Addiction Studies, Brown University
  • Dr. Lorenzo Leggio, M.D., Ph.D., M.Sc., Chief of Clinical Psychoneuroendocrinology and Neuropsychopharmacology, NIAAA/NIDA
  • Dr. Markus Heilig, M.D., Ph.D., Former Chief of the Laboratory of Clinical Studies (LCS), and Clinical Director of NIAAA's Division of Intramural Clinical and Biological Research

Visit http://www.aprescriptionforalcoholics.com/press-kit/ for downloadable digital assets, quotes from topic experts, statistics about alcoholism, book synopsis, and more.

Press Release References:

1. Addiction Medicine: Closing the Gap Between Science & Practice -  CASAColumbia

2. Dodes L. The Sober Truth: Debunking the Bad Science Behind 12-Step Programs and the Rehab Industry [Internet]. Book.

3. Volkow ND, Koob G. Brain disease model of addiction: why is it so controversial? The Lancet Psychiatry, Elsevier; 2015 Aug 8

4. Glaser G. The Irrationality of Alcoholics Anonymous, The Atlantic. 2015

5. Kraft S. WHO Study: Alcohol Is International Number One Killer, AIDS Second MedicalNewsToday.com. 2011 

email [email protected] 
Serious press inquiries will receive an immediate reply.

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com

SOURCE Linda Burlison

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.